Publication date: 17 june 2015
At the XXI Pharmaceutical Adam Smith Forum, Aston Group representatives took part in the discussion titled “Future of the reimbursement system and the further development of pilot projects.
Igor Petrushin, Head of Marketing Research and Consulting, Aston Group made a report on the present state of the drug supply in Russia. The presented analysis of current trends and implications for the drug supply landscape was of interest to all panel participants.
The speaker demonstrated the evolution of health care spending, described the the key directions for drug reimbursement in Russia and offered some valuable insights.
More information about the presentation is available here
|